Jie Wang

Jie Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
PXPan Lin Xin
Pan Lin Xin
LJLi Fan Jie
Li Fan Jie
QCQian Cheng
Qian Cheng
JWJie Wang
Jie Wang
WCWendan Cheng
Wendan Cheng
It is well known that RA (Rheumatoid arthritis) is an autoimmune disease characterized by multiple and symmetric arthropathy. The main pathological features of RA are synovial hyperplasia, angiogenesis, pannus formation, inflammatory cell infiltration, articular cartilage, bone destruction, and ultimately joint dysfunction, even deformity. IL-35 (Interleukin-35) is a new member of the IL-12 (Interleukin-12) family, which is an immunosuppressive and anti-inflammatory cytokine secreted mainly by Treg (T regulatory cells). There is evidence suggested that IL-35 can attenuate the progression of RA through influencing the immune and pathological process. It suggests that IL-35 played an important role in the pathogenesis of RA, and can be used as a potential target for the future treatment of RA. This review summarizes the recent advances of IL-35 in the pathological roles and the therapeutic potential roles in RA.

10 March 2025 in Journal of Analysis and Testing
Verified
Journal Article
Closed access
PDF file
JPJiabing Peng
Jiabing Peng
LCLijuan Chen
Lijuan Chen
BLBingyong Lin
Bingyong Lin
HTHehe Tang
Hehe Tang
WCWei Chang
Wei Chang
Jie WangJie Wang
Jie Wang

1 November 2020 in Journal of Orthopaedics
Verified
Journal Article
Closed access
FLFanjie Li
Fanjie Li
JWJie Wang
Jie Wang